Danske Bank A/S
26.3.2026 15:20:49 CET | Globenewswire | Press release
Danske Bank A/S, transactions by persons discharging managerial responsibilities
Danske Bank A/S, transactions by persons discharging managerial responsibilities
26 March 2026
Notification no. 20/2026
Transactions made by persons obliged to report transactions to the Danish FSA and Nasdaq Copenhagen, cf. the EU Market Abuse Regulation.
For further details, please find the attached template for notifications and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
The notifications relate to conditional shares granted to members of the Executive Leadership Team, as part of performance-based remuneration for previous financial years, which have been transferred to their respective accounts.
Contact: Stefan Kailay Wind, Head of Corporate Communications & Media Relations, tel. +45 45 14 14 00
Attachments
- Karsten Breum - transferred to account
- Johanna Norberg - transferred to account
- Dorthe Tolborg - transferred to account
- Frans Woelders - transferred to account
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Chery Group8.10.2026 01:08:30 CEST | Press release
FREELANDER Details Powertrain, Battery and All-Terrain Technology for International Left-Hand Drive FREELANDER 8
Chongqing Changan Automobile Co., Ltd.7.10.2026 21:38:36 CEST | Press release
Changan Automobile to Make Major Announcements at Mondial de l'Auto 2026
Oma Säästöpankki Oyj7.10.2026 20:30:00 CEST | Press release
Notification under Chapter 9, Section 10 of the Securities Market Act: Holdings of S-Bank Plc in Oma Savings Bank Plc has exceeded 90 percent
Oma Säästöpankki Oyj7.10.2026 19:30:00 CEST | Press release
Notification under Chapter 9, Section 10 of the Securities Market Act: Holdings of Parkanon Säästöpankkisäätiö in Oma Savings Bank Plc has fallen below the flagging threshold
Zealand Pharma7.10.2026 19:13:53 CEST | Press release
Zealand Pharma announces positive Phase 2 ZUPREME-2 topline results for amylin analog petrelintide in people with overweight or obesity and type 2 diabetes
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom